Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell P Levesque

Showing results (101-110 of 203) with videos related to

Pageof 21
Sort By:
Pigment Cell & Melanoma Research|November 6, 2025
Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant MelanomaFlavia L Tellenbach, Luzia Seiler, Mark Johnson, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 27, 2025
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma CellsAlessandra S P Cereghetti, Patrick Turko, Phil Cheng, et al.
Plos Biology|April 28, 2006
Whole-genome analysis of the SHORT-ROOT developmental pathway in ArabidopsisMitchell P Levesque, Teva Vernoux, Wolfgang Busch, et al.
Oncotarget|December 2, 2016
Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migrationVida Farsam, Abhijit Basu, Martina Gatzka, et al.
Cancers|March 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in SwitzerlandRamon Staeger, Julia M Martínez-Gómez, Patrick Turko, et al.
The Journal of Investigative Dermatology|May 12, 2020
Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase InhibitionMai Q Nguyen, Jessica L F Teh, Timothy J Purwin, et al.
Molecular Cancer Therapeutics|June 28, 2015
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2Sandra N Freiberger, Phil F Cheng, Guergana Iotzova-Weiss, et al.
Frontiers in Immunology|June 7, 2022
Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor PrognosisRajia Bahri, Orsolya Kiss, Ian Prise, et al.
Nature Chemical Biology|October 31, 2017
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancerYi Qu, Jan Roger Olsen, Xing Yuan, et al.
Cell Death & Disease|May 29, 2026
NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasisMichela Di Filippo, Tugay Karakaya, Marta Slaufova, et al.
Pageof 21

Showing results (101-110 of 203) with videos related to

Sort By:
Pageof 21
Pigment Cell & Melanoma Research|November 6, 2025
Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant MelanomaFlavia L Tellenbach, Luzia Seiler, Mark Johnson, et al.
JID Innovations : Skin Science From Molecules to Population Health|January 27, 2025
DNA Methyltransferase Inhibition Upregulates the Costimulatory Molecule ICAM-1 and the Immunogenic Phenotype of Melanoma CellsAlessandra S P Cereghetti, Patrick Turko, Phil Cheng, et al.
Plos Biology|April 28, 2006
Whole-genome analysis of the SHORT-ROOT developmental pathway in ArabidopsisMitchell P Levesque, Teva Vernoux, Wolfgang Busch, et al.
Oncotarget|December 2, 2016
Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migrationVida Farsam, Abhijit Basu, Martina Gatzka, et al.
Cancers|March 13, 2024
Real-World Data on Clinical Outcomes and Treatment Management of Advanced Melanoma Patients: Single-Center Study of a Tertiary Cancer Center in SwitzerlandRamon Staeger, Julia M Martínez-Gómez, Patrick Turko, et al.
The Journal of Investigative Dermatology|May 12, 2020
Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase InhibitionMai Q Nguyen, Jessica L F Teh, Timothy J Purwin, et al.
Molecular Cancer Therapeutics|June 28, 2015
Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2Sandra N Freiberger, Phil F Cheng, Guergana Iotzova-Weiss, et al.
Frontiers in Immunology|June 7, 2022
Human Melanoma-Associated Mast Cells Display a Distinct Transcriptional Signature Characterized by an Upregulation of the Complement Component 3 That Correlates With Poor PrognosisRajia Bahri, Orsolya Kiss, Ian Prise, et al.
Nature Chemical Biology|October 31, 2017
Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancerYi Qu, Jan Roger Olsen, Xing Yuan, et al.
Cell Death & Disease|May 29, 2026
NLRP1 inflammasome activation in skin equivalents reveals mechanistic insights into the roles of keratinocytes in psoriasisMichela Di Filippo, Tugay Karakaya, Marta Slaufova, et al.
Pageof 21